BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9796740)

  • 1. The influence of the hinge region length in binding of human IgG to human Fcgamma receptors.
    Redpath S; Michaelsen TE; Sandlie I; Clark MR
    Hum Immunol; 1998 Nov; 59(11):720-7. PubMed ID: 9796740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52.
    Redpath S; Michaelsen T; Sandlie I; Clark MR
    Immunology; 1998 Apr; 93(4):595-600. PubMed ID: 9659234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region.
    Michaelsen TE; Aase A; Norderhaug L; Sandlie I
    Mol Immunol; 1992 Mar; 29(3):319-26. PubMed ID: 1557042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1.
    Leoh LS; Daniels-Wells TR; Martínez-Maza O; Penichet ML
    Mol Immunol; 2015 Oct; 67(2 Pt B):407-15. PubMed ID: 26232328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcgammaRIIa expression with FcgammaRI results in C-reactive protein- and IgG-mediated phagocytosis.
    Bodman-Smith KB; Gregory RE; Harrison PT; Raynes JG
    J Leukoc Biol; 2004 Jun; 75(6):1029-35. PubMed ID: 15075346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
    Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
    PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FcγR Binding and ADCC Activity of Human IgG Allotypes.
    de Taeye SW; Bentlage AEH; Mebius MM; Meesters JI; Lissenberg-Thunnissen S; Falck D; Sénard T; Salehi N; Wuhrer M; Schuurman J; Labrijn AF; Rispens T; Vidarsson G
    Front Immunol; 2020; 11():740. PubMed ID: 32435243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human FcgammaRIIIa as a GPI-linked molecule on CHO cells to enable measurement of human IgG binding.
    Armour KL; Smith CS; Clark MR
    J Immunol Methods; 2010 Mar; 354(1-2):20-33. PubMed ID: 20138184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different glycosylation pattern of human IgG1 and IgG3 antibodies isolated from transiently as well as permanently transfected cell lines.
    Vestrheim AC; Moen A; Egge-Jacobsen W; Bratlie DB; Michaelsen TE
    Scand J Immunol; 2013 May; 77(5):419-28. PubMed ID: 23488770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses.
    Bruhns P; Iannascoli B; England P; Mancardi DA; Fernandez N; Jorieux S; Daëron M
    Blood; 2009 Apr; 113(16):3716-25. PubMed ID: 19018092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass.
    Deveuve Q; Lajoie L; Barrault B; Thibault G
    Front Immunol; 2020; 11():168. PubMed ID: 32117299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein specifically binds to Fcgamma receptor type I on a macrophage-like cell line.
    Tron K; Manolov DE; Röcker C; Kächele M; Torzewski J; Nienhaus GU
    Eur J Immunol; 2008 May; 38(5):1414-22. PubMed ID: 18412163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
    MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycine 236 in the Lower Hinge Region of Human IgG1 Differentiates FcγR from Complement Effector Function.
    Brinkhaus M; Douwes RGJ; Bentlage AEH; Temming AR; de Taeye SW; Tammes Buirs M; Gerritsen J; Mok JY; Brasser G; Ligthart PC; van Esch WJE; Verheesen P; de Haard H; Rispens T; Vidarsson G
    J Immunol; 2020 Dec; 205(12):3456-3467. PubMed ID: 33188070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
    Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
    J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins.
    Tan LK; Shopes RJ; Oi VT; Morrison SL
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):162-6. PubMed ID: 2296577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Fcγ receptors compete for TGN1412 binding that determines the antibody's effector function.
    Dudek S; Weißmüller S; Anzaghe M; Miller L; Sterr S; Hoffmann K; Hengel H; Waibler Z
    Eur J Immunol; 2019 Jul; 49(7):1117-1126. PubMed ID: 31002172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
    Hadley AG; Zupanska B; Kumpel BM; Leader KA
    Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge.
    Michaelsen TE; Brekke OH; Aase A; Sandin RH; Bremnes B; Sandlie I
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9243-7. PubMed ID: 7937748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a three amino acid deletion in the CH2 domain of murine IgG1 on Fc-associated effector functions.
    Baudino L; Nimmerjahn F; Shinohara Y; Furukawa J; Petry F; Verbeek JS; Nishimura S; Ravetch JV; Izui S
    J Immunol; 2008 Sep; 181(6):4107-12. PubMed ID: 18768867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.